His-Tag Antibody Market Outlook (2026–2030): Growth Drivers and Projections
The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
From Its 2026 Market Size, What Value Is The Histidine Tag (His-Tag) Antibody Market Projected To Reach By 2030?
The histidine tag (his-tag) antibody market has seen rapid expansion in recent years. Its value is expected to increase from $1.43 billion in 2025 to $1.6 billion in 2026, at a compound annual growth rate (CAGR) of 11.8%. The growth recorded historically can be attributed to several factors, including an increase in recombinant protein research, the expansion of academic life science laboratories, a greater use of affinity purification techniques, the availability of standardized tagging methods, and rising financial support for molecular biology research.
The histidine tag (his-tag) antibody market size is projected for substantial expansion in the upcoming years, with an expected value of $2.48 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 11.5%. This growth during the forecast period is fueled by factors such as the escalating demand for sophisticated protein analysis instruments, the enlargement of biopharmaceutical research pipelines, the increasing embrace of recombinant and nanobody formats, a heightened emphasis on the sensitivity and accuracy of assays, and the increasing incorporation of automation into laboratory procedures. Prominent trends observed in this period include an amplified need for highly specific research antibodies, the expanding application of his-tag antibodies in protein purification, the wider adoption of recombinant antibody formats, an increase in studies focused on tagged protein expression, and a strengthened commitment to reproducibility in life science research.
Access Your Free Sample Report For In-Depth Market Analysis:
What Primary Drivers Are Shaping The Histidine Tag (His-Tag) Antibody Market?
The increasing need for biopharmaceuticals is anticipated to fuel expansion in the histidine tag (His-Tag) antibody market. Biopharmaceuticals are defined as therapeutic agents derived from biological sources or biotechnological processes, as opposed to traditional chemical synthesis. This escalating demand stems from the growing incidence of chronic and intricate diseases, which necessitates advanced, targeted treatments that conventional medications often cannot adequately address. Histidine tag (His-Tag) antibodies play a crucial role in biopharmaceutical research by facilitating accurate detection and purification of recombinant proteins, thereby becoming indispensable for drug development and the creation of therapeutic proteins. Their high specificity and reproducibility minimize experimental inaccuracies, enhancing research effectiveness and the dependability of bioprocesses. An illustrative example is seen in June 2025, where, as reported by the Centers for Medicare & Medicaid Services (CMS), a US federal agency, prescription drug spending increased by 11.4% in 2023, reaching $449.7 billion, a significant acceleration from the 7.8% growth recorded in 2022. Consequently, the heightened demand for biopharmaceuticals is propelling the growth of the histidine tag (His-Tag) antibody market.
How Is The Histidine Tag (His-Tag) Antibody Market Categorized Across Its Segment Groups?
The histidine tag (his-tag) antibody market covered in this report is segmented –
1) By Product Type: Monoclonal Antibodies, Polyclonal Antibodies, Recombinant Antibodies, Nanobodies, Other Product Types
2) By Application: Western Blotting, Immunoprecipitation, Flow Cytometry, Other Applications
3) By End-User: Pharmaceutical Companies, Biotechnology Companies, Academic and Research Institutions, Contract Research Organizations (CROs), Other End-Users
Subsegments:
1) By Monoclonal Antibodies: Mouse Monoclonal, Rabbit Monoclonal, Rat Monoclonal, Humanized Monoclonal, Chimeric Monoclonal, Isotype Control Monoclonal
2) By Polyclonal Antibodies: Rabbit Polyclonal, Goat Polyclonal, Chicken Polyclonal, Donkey Polyclonal, Sheep Polyclonal, Serum Free Polyclonal
3) By Recombinant Antibodies: Recombinant Rabbit Monoclonal, Recombinant Mouse Monoclonal, Single Chain Variable Fragment, Fragment Antigen Binding, Multispecific Engineered Antibody, Recombinant Antibody Pair Capture And Detection
4) By Nanobodies: Single Domain Antibody Camelid, Single Domain Antibody Alpaca, Fluorescent Protein Fused Nanobody, Enzyme Conjugated Nanobody, Immobilized Nanobody For Affinity Purification, Intrabody Nanobody For Intracellular Detection
5) By Other Product Types: Secondary Antibodies Against Histidine Tag, Conjugated Secondary Antibodies Against Histidine Tag, Magnetic Beads Nickel Nitrilotriacetic Acid, Agarose Beads Nickel Nitrilotriacetic Acid, Enzyme Linked Immunosorbent Assay Kits For Histidine Tag, Lateral Flow Assays For Histidine Tag
What Trends Are Affecting The Growth Of The Histidine Tag (His-Tag) Antibody Market?
Major companies operating in the **histidine tag (His-Tag) antibody market** are focusing on developing advanced products, such as automated biosensor-based His-tag quantification kits, to accelerate and standardize protein detection from crude and purified samples. Automated biosensor-based His Tag quantification kits refer to commercial assay kits that use biosensor technology to detect and measure His-tagged proteins automatically. For instance, in **November 2025**, **HexagonFab Limited (trading as Abselion)**, a UK-based life-science tools company, launched the **Tagged Protein Quantification Kit or His-tag** and **Tagged Protein Sensor or His-tag Quantification**. It is built for the **Amperia platform** and developed with **GenScript’s THE His Tag monoclonal antibodies**. The automated biosensor-based His-tag quantification kit provides a rapid, mix-and-read, antibody-free method for quantifying His-tagged proteins directly in crude samples. When used with **Abselion’s Amperia biosensors**, the system enables real-time, label-free analysis, streamlining the protein characterization workflow without the need for multiple, separate instruments. Its main purpose is to accelerate expression screening, bioprocess optimization, and quality control by providing dependable His-tagged protein measurements without specialist training.
Which Firms Are Influencing Competition In The Histidine Tag (His-Tag) Antibody Market?
Major companies operating in the histidine tag (his-tag) antibody market are Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, Bio-Rad Laboratories Inc., GeneTex Inc., Bio-Techne Corporation, GenScript Biotech Corporation, Sino Biological Inc., Cell Signaling Technology Inc., Wuhan Elabscience Biotechnology Co. Ltd., ABclonal Technology Co. Ltd., Proteintech Group Inc., Santa Cruz Biotechnology Inc., Rockland Immunochemicals Inc., Creative Diagnostics Inc., Aviva Systems Biology Corporation, Abnova Corporation, Boster Biological Technology Co. Ltd., Columbia Biosciences Corporation, NSJ Bioreagents
Get The Full Histidine Tag (His-Tag) Antibody Market Report:
Which Region Is The Top Contributor To The Histidine Tag (His-Tag) Antibody Market By Share?
North America was the largest region in the histidine tag (His-Tag) antibody market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the histidine tag (his-tag) antibody market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Histidine Tag (His-Tag) Antibody Market Report For Competitive Insights:
Browse Through More Reports Similar to the Global Histidine Tag (His-Tag) Antibody Market 2026, By The Business Research Company
Monoclonal Antibodies Market Report 2026
https://www.thebusinessresearchcompany.com/report/monoclonal-antibodies-global-market-report
Diagnostic Specialty Antibodies Market Report 2026
Polyclonal Antibodies Market Report 2026
https://www.thebusinessresearchcompany.com/report/polyclonal-antibodies-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
